Yatin Suneja
Stock Analyst at Guggenheim
(4.69)
# 164
Out of 5,122 analysts
152
Total ratings
59.85%
Success rate
25.06%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $50 | $13.86 | +260.75% | 1 | Feb 2, 2026 | |
| ALMS Alumis | Maintains: Buy | $18 → $32 | $26.83 | +19.29% | 3 | Jan 7, 2026 | |
| SABS SAB Biotherapeutics | Initiates: Buy | $15 | $4.11 | +264.96% | 1 | Dec 19, 2025 | |
| DBVT DBV Technologies | Maintains: Buy | $35 → $51 | $22.36 | +128.09% | 2 | Dec 17, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $540 → $760 | $308.22 | +146.58% | 4 | Dec 9, 2025 | |
| IFRX InflaRx | Maintains: Buy | $10 → $22 | $0.84 | +2,531.26% | 6 | Nov 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $100 | $48.17 | +107.60% | 14 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $200 → $205 | $185.77 | +10.35% | 9 | Nov 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $815 → $865 | $767.64 | +12.68% | 8 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Buy | $14 | $1.99 | +603.52% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $57.72 | +21.29% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $32.86 | +82.59% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $111.25 | +34.83% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $128 | $6.91 | +1,752.39% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $14.55 | +37.46% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $843.00 | +26.93% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $21 | $21.60 | -2.78% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $48.16 | +107.64% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $30.50 | +145.90% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.43 | +517.28% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $139.01 | +25.89% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.22 | +708.71% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $14.27 | +103.22% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $13.09 | -8.33% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.87 | +155.54% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $25.38 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $21.28 | +111.47% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $23.75 | +89.47% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $24.02 | -16.74% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.94 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $32.90 | +97.57% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $23.82 | +277.91% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.43 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $41.04 | +19.40% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.21 | +316.35% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $186.72 | +87.45% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.56 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $16.34 | +46.92% | 1 | May 31, 2022 |
Avalo Therapeutics
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $13.86
Upside: +260.75%
Alumis
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $26.83
Upside: +19.29%
SAB Biotherapeutics
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $4.11
Upside: +264.96%
DBV Technologies
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $22.36
Upside: +128.09%
Praxis Precision Medicines
Dec 9, 2025
Maintains: Buy
Price Target: $540 → $760
Current: $308.22
Upside: +146.58%
InflaRx
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $0.84
Upside: +2,531.26%
AnaptysBio
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $48.17
Upside: +107.60%
Axsome Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $185.77
Upside: +10.35%
Regeneron Pharmaceuticals
Oct 29, 2025
Maintains: Buy
Price Target: $815 → $865
Current: $767.64
Upside: +12.68%
Neumora Therapeutics
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $1.99
Upside: +603.52%
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $57.72
Upside: +21.29%
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $32.86
Upside: +82.59%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $111.25
Upside: +34.83%
Oct 8, 2025
Maintains: Buy
Price Target: $112 → $128
Current: $6.91
Upside: +1,752.39%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $14.55
Upside: +37.46%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $843.00
Upside: +26.93%
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $21.60
Upside: -2.78%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $48.16
Upside: +107.64%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $30.50
Upside: +145.90%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.43
Upside: +517.28%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $139.01
Upside: +25.89%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.22
Upside: +708.71%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $14.27
Upside: +103.22%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $13.09
Upside: -8.33%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $5.87
Upside: +155.54%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $25.38
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $21.28
Upside: +111.47%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $23.75
Upside: +89.47%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $24.02
Upside: -16.74%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.94
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $32.90
Upside: +97.57%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $23.82
Upside: +277.91%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $41.04
Upside: +19.40%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.21
Upside: +316.35%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $186.72
Upside: +87.45%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.56
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $16.34
Upside: +46.92%